Many patients with clinical MEN-1 may have negative testing for MEN1 mutations due to genetic abnormalities in noncoding regions or whole-gene deletions, detection of which requires more extensive DNA sequencing analysis (12). Here, MEN1 is linked to multiple endocrine neoplasia type 1.